Ariana Pharma Receives $1.5 Million
Ariana Pharma, a drug discovery and development services business, will receive EUR 1 million ($1.5 million) from France's innovation agency, OSEO, as part of the IMAkinib program. IMAkinib is a collaborative program to develop biomarkers for oncology.
13 October 2009•3 mins read
